Niacin Lipid Profile Meta-Analysis Evidence Table

Structured evidence table for Niacin Lipid Profile Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Niacin Lipid Profile Meta-AnalysisAlthough triglyceride elevation alone does not necessarily increase the risk of complications, higher triglyceride levels have been linked to maternal disorders such as preeclampsia, gestational hypertension, and acute pancreatitis, as well as adverse fetal outcomes, including abnormal birth weight and preterm delivery.4Chamerski S (2026)Navigating hypertriglyceridemia in pregnancy: current evidence and clinical strategies.
Niacin Lipid Profile Meta-AnalysisIn severe hypertriglyceridemia with imminent pancreatitis risk, rapid interventions such as pharmacotherapy or therapeutic plasma exchange are required to promptly reduce triglyceride levels.4Chamerski S (2026)Navigating hypertriglyceridemia in pregnancy: current evidence and clinical strategies.
Niacin Lipid Profile Meta-AnalysisThis narrative review synthesizes current evidence on the pathophysiology, prognostic implications, and management of hypertriglyceridemia in pregnancy, emphasizing early risk identification, first-trimester lipid assessment, and individualized treatment aligned with the updated ESC/EAS guidelines.4Chamerski S (2026)Navigating hypertriglyceridemia in pregnancy: current evidence and clinical strategies.
Niacin Lipid Profile Meta-AnalysisPregnancy induces profound metabolic adaptations, including marked rises in lipid concentrations.4Chamerski S (2026)Navigating hypertriglyceridemia in pregnancy: current evidence and clinical strategies.
Niacin Lipid Profile Meta-AnalysisSince its discovery over half a century ago, Lp(a) has attracted considerable interest due to its strong, genetically determined association with atherosclerotic cardiovascular disease (ASCVD), independent of traditional lipid risk factors.4Domański Igor (2026)Existing and Potential Therapeutic Strategies for Lowering Lipoprotein(a) Levels: An Update
Niacin Lipid Profile Meta-AnalysisElevated Lp(a) concentrations—particularly those above 50 mg/dL—have been strongly linked to an increased risk of myocardial infarction, ischemic stroke, peripheral artery disease, heart failure, and aortic valve stenosis.4Domański Igor (2026)Existing and Potential Therapeutic Strategies for Lowering Lipoprotein(a) Levels: An Update
Niacin Lipid Profile Meta-AnalysisThere is a lot of evidence from studies of people that supports the idea that high levels of Lp(a) cause atherosclerosis, stroke and problems with the valves in the heart.4Domański Igor (2026)Existing and Potential Therapeutic Strategies for Lowering Lipoprotein(a) Levels: An Update
Niacin Lipid Profile Meta-Analysis1 Lipoprotein(a) [Lp(a)] is a lipoprotein particle structurally related to low-density lipoprotein (LDL), but characterized by the presence of an additional apolipoprotein(a) [apo(a)] component, covalently linked to apolipoprotein B-100 via a disulfide bond [].4Domański Igor (2026)Existing and Potential Therapeutic Strategies for Lowering Lipoprotein(a) Levels: An Update
topicNiacin Lipid Profile Meta-Analysis
claimAlthough triglyceride elevation alone does not necessarily increase the risk of complications, higher triglyceride levels have been linked to maternal disorders such as preeclampsia, gestational hypertension, and acute pancreatitis, as well as adverse fetal outcomes, including abnormal birth weight and preterm delivery.
evidence level4
citationChamerski S (2026)
sourceNavigating hypertriglyceridemia in pregnancy: current evidence and clinical strategies.
topicNiacin Lipid Profile Meta-Analysis
claimIn severe hypertriglyceridemia with imminent pancreatitis risk, rapid interventions such as pharmacotherapy or therapeutic plasma exchange are required to promptly reduce triglyceride levels.
evidence level4
citationChamerski S (2026)
sourceNavigating hypertriglyceridemia in pregnancy: current evidence and clinical strategies.
topicNiacin Lipid Profile Meta-Analysis
claimThis narrative review synthesizes current evidence on the pathophysiology, prognostic implications, and management of hypertriglyceridemia in pregnancy, emphasizing early risk identification, first-trimester lipid assessment, and individualized treatment aligned with the updated ESC/EAS guidelines.
evidence level4
citationChamerski S (2026)
sourceNavigating hypertriglyceridemia in pregnancy: current evidence and clinical strategies.
topicNiacin Lipid Profile Meta-Analysis
claimPregnancy induces profound metabolic adaptations, including marked rises in lipid concentrations.
evidence level4
citationChamerski S (2026)
sourceNavigating hypertriglyceridemia in pregnancy: current evidence and clinical strategies.
topicNiacin Lipid Profile Meta-Analysis
claimSince its discovery over half a century ago, Lp(a) has attracted considerable interest due to its strong, genetically determined association with atherosclerotic cardiovascular disease (ASCVD), independent of traditional lipid risk factors.
evidence level4
citationDomański Igor (2026)
sourceExisting and Potential Therapeutic Strategies for Lowering Lipoprotein(a) Levels: An Update
topicNiacin Lipid Profile Meta-Analysis
claimElevated Lp(a) concentrations—particularly those above 50 mg/dL—have been strongly linked to an increased risk of myocardial infarction, ischemic stroke, peripheral artery disease, heart failure, and aortic valve stenosis.
evidence level4
citationDomański Igor (2026)
sourceExisting and Potential Therapeutic Strategies for Lowering Lipoprotein(a) Levels: An Update
topicNiacin Lipid Profile Meta-Analysis
claimThere is a lot of evidence from studies of people that supports the idea that high levels of Lp(a) cause atherosclerosis, stroke and problems with the valves in the heart.
evidence level4
citationDomański Igor (2026)
sourceExisting and Potential Therapeutic Strategies for Lowering Lipoprotein(a) Levels: An Update
topicNiacin Lipid Profile Meta-Analysis
claim1 Lipoprotein(a) [Lp(a)] is a lipoprotein particle structurally related to low-density lipoprotein (LDL), but characterized by the presence of an additional apolipoprotein(a) [apo(a)] component, covalently linked to apolipoprotein B-100 via a disulfide bond [].
evidence level4
citationDomański Igor (2026)
sourceExisting and Potential Therapeutic Strategies for Lowering Lipoprotein(a) Levels: An Update

Source documents

  1. Navigating hypertriglyceridemia in pregnancy: current evidence and clinical strategies.
  2. Existing and Potential Therapeutic Strategies for Lowering Lipoprotein(a) Levels: An Update